Dokument: COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey

Titel:COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=68690
URN (NBN):urn:nbn:de:hbz:061-20250218-115014-1
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Kernder, Anna [Autor]
Filla, Tim [Autor]
Groot, Kirsten de [Autor]
Hellmich, Bernhard [Autor]
Holle, Julia [Autor]
Lamprecht, Peter [Autor]
Moosig, Frank [Autor]
Ruffer, Nikolas [Autor]
Specker, Christof [Autor]
Vordenbäumen, Stefan [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]376,3 KB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 18.02.2025 / geändert 18.02.2025
Stichwörter:patient survey, health care, vaccination coverage, systemic vasculitis, COVID-19
Beschreibung:Objective: To analyze the impact of the COVID-19 pandemic on medical care and vaccination acceptance of vasculitis patients in Germany.

Methods: A web-based national survey was developed by rheumatology centers and vasculitis patient advocacy groups. The survey was distributed nationwide by mail and flyers and could be accessed via a QR-code or weblink from December 2021 to April 2022. Descriptive statistics [mean, median, standard derivation (SD), 25%, 75% quantile] were calculated. 95% confidence intervals were presented for responses that were directly related to the impact of COVID-19 on parameters associated with vasculitis patient care.

Results: The online survey was completed by 117 patients with small and large vessel vasculitis [granulomatosis with polyangiitis (n = 69), eosinophilic granulomatosis with polyangiitis (n = 16), microscopic polyangiitis (n = 12), giant cell arteritis (n = 17) and Takayasu's arteritis (n = 3)]. Prescheduled rheumatological appointments had been canceled due to the COVID-19 pandemic in 12.6% of the respondents [95% confidence interval (CI), 7.3–20.0%); in 9% (95% CI, 4.5–15.6%)] appointments had been replaced by digital services. Therapeutic regimens were changed (shifted, reduced, or discontinued) due to the pandemic in 15.5% (95% CI 9.5–22.2%). Vaccination coverages were generally high compared to patients with other rheumatic diseases and the general population. Highest vaccination coverage was observed against COVID-19 (98.1% 95% CI 93.9–99.6%).

Conclusion: Vasculitis patients experienced changes in medical care during COVID-19 pandemic such as cancelation of prescheduled rheumatology appointments and modifications in therapeutic regimens. The overall acceptance rate for vaccination was comparatively high, particularly for vaccination against COVID-19.
Rechtliche Vermerke:Originalveröffentlichung:
Kernder, A. L., Filla, T., de Groot, K., Hellmich, B., Holle, J., Lamprecht, P., Moosig, F., Ruffer, N., Specker, C., Vordenbäumen, S., Schneider, M., & Chehab, G. (2023). COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey. Frontiers in Medicine, 9, Article 1103694. https://doi.org/10.3389/fmed.2022.1103694
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:18.02.2025
Dateien geändert am:18.02.2025
english
Benutzer
Status: Gast
Aktionen